Format

Send to

Choose Destination
See comment in PubMed Commons below
Nat Rev Genet. 2002 Dec;3(12):954-66.

Enzyme replacement and enhancement therapies: lessons from lysosomal disorders.

Author information

1
Department of Human Genetics, Mount Sinai School of Medicine at New York University, New York, New York 10029, USA. rjdesnick@mssm.edu

Erratum in

  • Nat Rev Genet. 2003 Feb;4(2):157..

Abstract

The past decade has witnessed remarkable advances in our ability to treat inherited metabolic disorders, especially the lysosomal storage diseases, a group of more than 40 disorders, each of which is caused by the deficiency of a lysosomal enzyme or protein. During the past few years, both enzyme replacement and enhancement therapies have been developed to treat these disorders. This review discusses the successes and shortcomings of these therapeutic strategies, and the contributions that they have made to treating lysosomal storage diseases.

PMID:
12459725
DOI:
10.1038/nrg963
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group
    Loading ...
    Support Center